VX-702 |
6-[(AMINOCARBONYL)(2,6-DIFLUOROPHEN YL)AMINO]-2-(2,4-DIFLUOROPHENYL)-3-PYRIDINECARBOXAMIDE |
6-(N-CARBAMOYL-2,6-DIFLUOROANILINO)-2-(2,4-DIFLUOROPHENYL)PYRIDINE-3-CARBOXAMIDE |
6-(N-CARBAMOYL-2,6-DIFLUORO-ANILINO)-2-(2,4-DIFLUOROPHENYL)PYRIDINE-3-CARBOXAMIDE |
479543-46-9 , C19H12F4N4O2 , VX702 , VX 702 |
BRD-K07736136-001-01-2 |
W-5489 |
S-7778 |
A19416 |
EC-000.2363 |
Y0260 |
FT-0696780 |
FT-0675854 |
FT-0652364 |
RT-016249 |
KB-198954 |
SMR004702934 |
KB-81473 |
HY-10401 |
HE067027 |
BC665780 |
4CA-1339 |
NCGC00249684-01 |
6-[CARBAMOYL-(2,6-DIFLUOROPHENYL)AMINO]-2-(2,4-DIFLUOROPHENYL)PYRIDINE-3-CARBOXAMIDE |
VX-702-SUPPLIED BY SELLECK CHEMICALS |
CS-0074 |
AN-5334 |
AKOS015902395 |
ZINC36377992 |
VX-702/VX702 |
RS0060 |
DCL000260 |
BDBM50314071 |
ABP000258 |
HMS3244H12 |
HMS3244H08 |
HMS3244H04 |
BCPP000016 |
MOLPORT-021-805-020 |
FYSRKRZDBHOFAY-UHFFFAOYSA-N |
CHEBI:719385 |
SYN1093 |
QCR-232 |
AOB6303 |
CTK8E9206 |
GTPL6059 |
SCHEMBL185712 |
MLS006011165 |
PUBCHEM22492 |
CID10341154 |
6-[(AMINOCARBONYL)(2,6-DIFLUOROPHENYL)AMINO]-2-(2,4-DIFLUOROPHENYL)-3-PYRIDINECARBOXAMIDE |
VX702, VX-702 |
C19H12F4N4O2 |
2-(2,4-DIFLUOROPHENYL)-6-[1-(2,6-DIFLUOROPHENYL)CARBAMOYLAMINO]PYRIDINE-3-CARBOXAMIDE |
ST51054128 |
1-(5-CARBAMOYL-6-(2,4-DIFLUOROPHENYL)PYRIDIN-2-YL)-1-(2,6-DIFLUOROPHENYL)UREA |
I14-1965 |
KINOME_3176 |
S6005_SELLECK |
2-(2,4-DIFLUOROPHENYL)-6-(1-(2,6-DIFLUOROPHENYL)UREIDO)NICOTINAMIDE |
745833-23-2 |
VX702 |
VX 702 |
479543-46-9 |
10341154 |
AB0035846 |
DB05470 |
178102680 |
6059 |
85154293 |
FDA Approval | not approved |
Drug Class | small molecule |
Drug Indications | antiinflammatory agent,cardiovascular agent |
Drug Categories | urea |
Drug Categories | organic chemicals |
Drug Categories | hydrocarbons, cyclic |
Drug Categories | hydrocarbons, aromatic |
Drug Categories | hydrocarbons |
Drug Categories | benzene derivatives |
Drug Groups | investigational |
Drug Type | small molecule |
inhibitor |
Mechanism of Interaction | MAP kinase p38 alpha inhibitor |
Direct Interaction | yes |
Specific Action of the Ligand | Inhibition |
inhibitor |
Specific Action of the Ligand | Inhibition |
Endogenous Drug? | False |
Direct Interaction? | True |
inhibitor |
Trial Name | VX-702 |
Novel drug target | Novel Target |
n/a |
Trial Name | VX-702 |
Novel drug target | Novel Target |
n/a |
n/a |
n/a |
VX-702 | DrugBank Drug Name |
Drug Type | small molecule |
Drug Groups | investigational |
Drug Categories | benzene derivatives |
Drug Indications | antiinflammatory agent,cardiovascular agent |
Drug Class | small molecule |
FDA Approval | not approved |
AB0035846 | Drug Synonym |
VX-702 | pubchem_primary_name |
10341154 | PubChem CID |
ST51054128 | Drug Synonym |
CHEMBL1090090 | Drug Synonym |
6-[CARBAMOYL-(2,6-DIFLUOROPHENYL)AMINO]-2-(2,4-DIFLUOROPHENYL)PYRIDINE-3-CARBOXAMIDE | Drug Synonym |
VX-702 | GuideToPharmacology Ligand Name |
178102680 | PubChem Drug SID |